The Food and Drug Administration (FDA) has granted market authorization for over a dozen ZYN nicotine pouch products, with the agency cautioning that no tobacco product is safe and that the pouches’ risk to young people is outweighed by their benefits to adult cigarette smokers.
The FDA said in a Jan. 16 announcement that, following a scientific review, it concluded that these nicotine pouches contain fewer harmful chemicals than combustible cigarettes and traditional smokeless tobacco, potentially reducing risks of cancer and respiratory disease for adult users transitioning from more dangerous sources of nicotine.
